<p>OPLS-DA results comparing metabolites from control (black, closed circles) and PD patients (red, open squares) (A). Discriminatory analysis of control and PD patient metabolic data (B). The green dots represent metabolites with 95% correlation to the first two principal components. The gold circles denote the top 1% of these metabolites (154 <i>m/z</i>) that most closely associate with control or PD. </p
<p>The 12 metabolites far from the origin that contributed significantly to differentiating the clus...
<p>Venn diagram representing the 15 best discriminating metabolites between patients in Group P and ...
(A) “Prostate disease” (HD (as a control group) vs BPH+PCa); (B) “PCa” (HD+BPH (as a control group) ...
<p>A manhattan plot (A) shows a number of metabolites that break the threshold of significance (dott...
<p>The OPLS-DA (orthogonal partial least square discriminant analysis) scores plot (A) shows cluster...
<p>A: Score plot obtained by PLS-DA with HCC cases labeled by red triangles and patients with liver ...
Supplementary Table S1. VIP list obtained from OPLS-DA analysis of PCOS and controls Supplementary t...
<p>Green dots represent features that show 95% separation between cases and controls; the gold circl...
<p>PLS-DA score's plot displays a significant separation between control subjects (n = 42) and unmed...
<p>Bar graphs represent the average concentration of serum metabolites for all time-points and doses...
<p>(A) OPLS-DA score plot for light AD patients (MMSE>22) vs. controls. (B) OPLS-DA coefficient plot...
<p>Bar graphs represent the average concentration of liver metabolites for all time-points and doses...
<p>(A) OPLS-DA score plot representing the 54 samples in the Tpred 1 vs Tpred 2 plane. (B, C-D) OPLS...
<p>Metabolite predictive loading values (p(corr)) in the OPLS-DA model between pre-symptomatic indiv...
<p>Metabolites have been classified according to their molecular structures or known metabolic funct...
<p>The 12 metabolites far from the origin that contributed significantly to differentiating the clus...
<p>Venn diagram representing the 15 best discriminating metabolites between patients in Group P and ...
(A) “Prostate disease” (HD (as a control group) vs BPH+PCa); (B) “PCa” (HD+BPH (as a control group) ...
<p>A manhattan plot (A) shows a number of metabolites that break the threshold of significance (dott...
<p>The OPLS-DA (orthogonal partial least square discriminant analysis) scores plot (A) shows cluster...
<p>A: Score plot obtained by PLS-DA with HCC cases labeled by red triangles and patients with liver ...
Supplementary Table S1. VIP list obtained from OPLS-DA analysis of PCOS and controls Supplementary t...
<p>Green dots represent features that show 95% separation between cases and controls; the gold circl...
<p>PLS-DA score's plot displays a significant separation between control subjects (n = 42) and unmed...
<p>Bar graphs represent the average concentration of serum metabolites for all time-points and doses...
<p>(A) OPLS-DA score plot for light AD patients (MMSE>22) vs. controls. (B) OPLS-DA coefficient plot...
<p>Bar graphs represent the average concentration of liver metabolites for all time-points and doses...
<p>(A) OPLS-DA score plot representing the 54 samples in the Tpred 1 vs Tpred 2 plane. (B, C-D) OPLS...
<p>Metabolite predictive loading values (p(corr)) in the OPLS-DA model between pre-symptomatic indiv...
<p>Metabolites have been classified according to their molecular structures or known metabolic funct...
<p>The 12 metabolites far from the origin that contributed significantly to differentiating the clus...
<p>Venn diagram representing the 15 best discriminating metabolites between patients in Group P and ...
(A) “Prostate disease” (HD (as a control group) vs BPH+PCa); (B) “PCa” (HD+BPH (as a control group) ...